12.66

4.28% 0.52

After Hours: 12.66

Biodesix Inc (BDSX)

Overview News Price History Option Chain Financials Discussions Forecast

Biodesix Inc stock is traded at $12.66, with a volume of 64,437. It is up +4.28% in the last 24 hours and down -29.19% over the past month. Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Previous Close:

$12.14

Open:

$12.25

24h Volume:

64,437

Relative Volume:

0.05

Market Cap:

$127.96M

Revenue:

$88.50M

Net Income/Loss:

$-35.27M

P/E Ratio:

-3.8417

EPS:

-3.2954

Net Cash Flow:

$-23.70M

1W Performance:

-11.16%

1M Performance:

-29.19%

6M Performance:

+70.62%

1Y Performance:

+10.66%

1-Day Range:

$12.25

$13.05

1-Week Range:

$12.13

$14.40

52-Week Range:

$3.436

$20.21

Biodesix Inc Stock (BDSX) Company Profile

Name

Biodesix Inc

Sector

Healthcare (1112)

Industry

Diagnostics & Research (52)

Phone

303-417-0500

Address

919 WEST DILLON ROAD, LOUISVILLE

Employee

334

Twitter

Next Earnings Date

2025-10-31

Latest SEC Filings

BDSX's Discussions on Twitter

Compare BDSX vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BDSX Biodesix Inc	12.66	122.70M	88.50M	-35.27M	-23.70M	-3.2954
TMO Thermo Fisher Scientific Inc	531.67	195.93B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	198.14	140.56B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	580.76	46.39B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	119.77	34.02B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	326.20	32.49B	3.17B	642.63M	516.49M	10.77

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-27-26	Upgrade	William Blair	Mkt Perform → Outperform
May-14-25	Downgrade	William Blair	Outperform → Mkt Perform
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy
May-13-24	Initiated	TD Cowen	Buy
May-03-24	Initiated	Lake Street	Buy
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-23-20	Initiated	BTIG Research	Buy
Nov-23-20	Initiated	Canaccord Genuity	Buy
Nov-23-20	Initiated	Morgan Stanley	Overweight
Nov-23-20	Initiated	William Blair	Outperform

View All

Biodesix Inc Stock (BDSX) Latest News

Apr 10, 2026

Aberdeen Group plc Takes $1.78 Million Position in Biodesix, Inc. $BDSX - MarketBeat

Apr 10, 2026

BDSX Stock Price, Quote & Chart | BIODESIX INC (NASDAQ:BDSX) - ChartMill

Apr 10, 2026

Apr 09, 2026

Biodesix (NASDAQ: BDSX) outlines 2026 virtual meeting, board and pay votes - Stock Titan

Apr 09, 2026

Employees put Biodesix on USA TODAY's Top Workplaces list for a third year - Stock Titan

Apr 09, 2026

Rate Hike: Can Biodesix Inc expand into new marketsQuarterly Portfolio Report & Accurate Buy Signal Notifications - baoquankhu1.vn

Apr 09, 2026

Apr 07, 2026